In the US, Zoladex (goserelin systemic) is a member of the following drug classes: gonadotropin releasing hormones, hormones/antineoplastics and is used to treat Bleeding Disorder, Breast Cancer - Palliative, Endometriosis and Prostate Cancer.
US matches:
- Zoladex
- Zoladex 3-Month
- Zoladex Implant
UK matches:
- Zoladex 3.6mg Implant
- Zoladex LA 10.8mg
- Zoladex 3.6mg Implant (SPC)
- Zoladex LA 10.8mg (AstraZeneca UK Limited) (SPC)
Ingredient matches for Zoladex
Goserelin
Goserelin is reported as an ingredient of Zoladex in the following countries:
- Ireland
- Taiwan
- Tunisia
Goserelin acetate (a derivative of Goserelin) is reported as an ingredient of Zoladex in the following countries:
- Argentina
- Aruba
- Australia
- Bahamas
- Bahrain
- Barbados
- Belgium
- Bermuda
- Bosnia & Herzegowina
- Brazil
- Canada
- Chile
- China
- Colombia
- Costa Rica
- Croatia (Hrvatska)
- Cyprus
- Czech Republic
- Denmark
- Dominican Republic
- Ecuador
- Egypt
- El Salvador
- Estonia
- Finland
- France
- Georgia
- Germany
- Ghana
- Greece
- Guatemala
- Haiti
- Honduras
- Hong Kong
- Hungary
- Iceland
- Indonesia
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Jamaica
- Japan
- Jordan
- Kenya
- Kuwait
- Latvia
- Lebanon
- Libya
- Lithuania
- Luxembourg
- Malawi
- Malaysia
- Malta
- Mexico
- Mozambique
- Netherlands
- Netherlands Antilles
- New Zealand
- Nicaragua
- Nigeria
- Norway
- Oman
- Panama
- Peru
- Philippines
- Poland
- Portugal
- Qatar
- Romania
- Russian Federation
- Saudi Arabia
- Serbia
- Singapore
- Slovenia
- South Africa
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Tanzania
- Thailand
- Trinidad & Tobago
- Turkey
- Uganda
- United Arab Emirates
- United Kingdom
- United States
- Vietnam
- Yemen
- Zambia
- Zimbabwe
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment